Global Genetic Testing Market Research and Forecast, 2018-2023
The global genetic testing market is expected to grow at a modest CAGR during 2018-2023. Genetic testing is a medical test that is used for the identification of changes in chromosomes or in genes. A suspected genetic condition can be confirmed or ruled out by the results of genetic testing. It enables the determination of the possibility of a person, developing or passing a genetic disorder. The rising prevalence of the genetic disorder is one of the major factors that is augmenting the genetic testing market. According to the Genesis foundation for children, in 2017, 1 in every 33 children in the US is born with an intellectual or genetic disorder. It is estimated that about 120,000 babies in the US are affected each year. All birth disorders cannot be prevented. However, there is an increased chance of having a healthy baby by genetic testing. Genetic testing provides early detection of any genetic disorder enabling it to be ruled out.
The factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, Alzheimer’s and so on. Apart from this, initiatives taken by the government such as the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative is significantly driving the market growth. EGAPP was launched by the Centers for Disease Control and Prevention in 2004. This initiative was aimed at the establishment and testing of an evidence-based process for the evaluation of genetic tests and other applications of genomic technology. In addition, increasing awareness of the people regarding genomics is accelerating the growth of the market.
Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America is growing at a very significant rate. The reason for this is that the presence of key industry players increased genetic diseases and supportive government initiatives. Moreover, the Asia-Pacific region is anticipated to be the fastest developing region during the forecast period. Factors such as increasing awareness among people and the growing focus of key industry players on emerging countries in the region are driving the growth of the market.
The companies contributing to the growth of global genetic testing market are Abbott Laboratories Inc., Applied Biosystems Inc., AutoGenomics Inc., BioRad Laboratories Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp. and so on. Majority of key players are acquiring or entering into strategic alliance with other key players from the market to gain a competitive edge over others and enhance their presence.
RESEARCH METHODOLOGY
The market study of the global genetic testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
THE REPORT COVERS
The factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, Alzheimer’s and so on. Apart from this, initiatives taken by the government such as the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative is significantly driving the market growth. EGAPP was launched by the Centers for Disease Control and Prevention in 2004. This initiative was aimed at the establishment and testing of an evidence-based process for the evaluation of genetic tests and other applications of genomic technology. In addition, increasing awareness of the people regarding genomics is accelerating the growth of the market.
Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America is growing at a very significant rate. The reason for this is that the presence of key industry players increased genetic diseases and supportive government initiatives. Moreover, the Asia-Pacific region is anticipated to be the fastest developing region during the forecast period. Factors such as increasing awareness among people and the growing focus of key industry players on emerging countries in the region are driving the growth of the market.
The companies contributing to the growth of global genetic testing market are Abbott Laboratories Inc., Applied Biosystems Inc., AutoGenomics Inc., BioRad Laboratories Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp. and so on. Majority of key players are acquiring or entering into strategic alliance with other key players from the market to gain a competitive edge over others and enhance their presence.
RESEARCH METHODOLOGY
The market study of the global genetic testing market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- An authentic database such as the National Society of Genetic Counselors, American Medical Association (AMA) and so on.
- Company websites and their product/ services catalog.
THE REPORT COVERS
- Comprehensive research methodology of the global genetic testing market.
- This report also includes a detailed and extensive market overview with analyst insights & key market trends.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global genetic testing market.
- Insights about market determinants which are stimulating the global genetic testing market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Rise in Genetic Diseases
3.1.2. Rising demand for Early Disease Detection and Prevention
3.1.3. Increasing Application of Genetic Testing in Oncology
3.1.4. Supportive Government Initiatives
3.2. Restraints
3.2.1. Strict Regulatory Policies
3.2.2. Issues Associated with Genetic Testing
3.2.3. High Cost of Genetic Testing
3.3. Opportunities
3.3.1. Technological Advancement
3.3.2. Growing Demand for Personalized Medicine
3.3.3. Investment in Research And Development
4. MARKET SEGMENTATION
4.1. Global Genetic Testing Market by Technology
4.1.1. Molecular Testing
4.1.2. Biochemical Testing
4.1.3. Other Testing
4.2. Global Genetic Testing Market by Type
4.2.1. Prenatal and New-Born Genetic Testing
4.2.2. Predictive Testing
4.2.3. Pre-Implantation Testing
4.2.4. Diagnostic Testing
4.2.5. Carrier Testing
4.2.6. Forensic Testing
4.3. Global Genetic Testing Market by Disease
4.3.1. Cancer
4.3.2. Alzheimer
4.3.3. Cystic Fibrosis
4.3.4. Fanconi Anaemia
4.3.5. Ducheme’s Muscular Dystrophy
4.3.6. Sickle Cell Anaemia
4.3.7. Others
5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Abbott Laboratories, Inc.
7.2. 23Andme, Inc.
7.3. AutoGenomics, Inc.
7.4. Biocartis SA
7.5. Biomerieux SA
7.6. Bio-Rad Laboratories, Inc.
7.7. Cepheid, Inc.
7.8. EKF Diagnostics
7.9. Elitech Group
7.10. Genentech, Inc.
7.11. Genomictree Inc.
7.12. Illumina, Inc.
7.13. IntegraGen S.A.
7.14. Interpace Diagnostics, LLC
7.15. Luminex Corporation
7.16. MedGenome, Inc.
7.17. Myriad Genetics, Inc.
7.18. PerkinElmer, Inc.
7.19. Qiagen N.V.
7.20. Quest Diagnostics, Inc.
7.21. Roche Molecular Systems, Inc.
7.22. Sequenom
7.23. Thermo Fisher Scientific, Inc.
7.24. Takara Bio, Inc.
7.25. Transgenomic, Inc.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Rise in Genetic Diseases
3.1.2. Rising demand for Early Disease Detection and Prevention
3.1.3. Increasing Application of Genetic Testing in Oncology
3.1.4. Supportive Government Initiatives
3.2. Restraints
3.2.1. Strict Regulatory Policies
3.2.2. Issues Associated with Genetic Testing
3.2.3. High Cost of Genetic Testing
3.3. Opportunities
3.3.1. Technological Advancement
3.3.2. Growing Demand for Personalized Medicine
3.3.3. Investment in Research And Development
4. MARKET SEGMENTATION
4.1. Global Genetic Testing Market by Technology
4.1.1. Molecular Testing
4.1.2. Biochemical Testing
4.1.3. Other Testing
4.2. Global Genetic Testing Market by Type
4.2.1. Prenatal and New-Born Genetic Testing
4.2.2. Predictive Testing
4.2.3. Pre-Implantation Testing
4.2.4. Diagnostic Testing
4.2.5. Carrier Testing
4.2.6. Forensic Testing
4.3. Global Genetic Testing Market by Disease
4.3.1. Cancer
4.3.2. Alzheimer
4.3.3. Cystic Fibrosis
4.3.4. Fanconi Anaemia
4.3.5. Ducheme’s Muscular Dystrophy
4.3.6. Sickle Cell Anaemia
4.3.7. Others
5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Abbott Laboratories, Inc.
7.2. 23Andme, Inc.
7.3. AutoGenomics, Inc.
7.4. Biocartis SA
7.5. Biomerieux SA
7.6. Bio-Rad Laboratories, Inc.
7.7. Cepheid, Inc.
7.8. EKF Diagnostics
7.9. Elitech Group
7.10. Genentech, Inc.
7.11. Genomictree Inc.
7.12. Illumina, Inc.
7.13. IntegraGen S.A.
7.14. Interpace Diagnostics, LLC
7.15. Luminex Corporation
7.16. MedGenome, Inc.
7.17. Myriad Genetics, Inc.
7.18. PerkinElmer, Inc.
7.19. Qiagen N.V.
7.20. Quest Diagnostics, Inc.
7.21. Roche Molecular Systems, Inc.
7.22. Sequenom
7.23. Thermo Fisher Scientific, Inc.
7.24. Takara Bio, Inc.
7.25. Transgenomic, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL MOLECULAR TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL BIOCHEMICAL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL OTHER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL PRENATAL AND NEWBORN TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL PREDICTIVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PRE-IMPLANTATION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL CARRIER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL FORENSIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL ALZHEIMER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL CYSTIC FIBROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL FANCONI ANEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL DUCHENE’S MUSCULAR DYSTROPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 24 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 25 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 26 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 27 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 28 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 29 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 30 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 31 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 32 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 33 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 34 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL MOLECULAR TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL BIOCHEMICAL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL OTHER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL PRENATAL AND NEWBORN TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL PREDICTIVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PRE-IMPLANTATION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL CARRIER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL FORENSIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL ALZHEIMER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL CYSTIC FIBROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL FANCONI ANEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL DUCHENE’S MUSCULAR DYSTROPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 20 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 24 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 25 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 26 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 27 EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 28 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 29 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 30 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 31 ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
TABLE # 32 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 33 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 34 REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES TYPE, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL GENETIC TESTING MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL GENETIC TESTING MARKET SHARE BY TYPE, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL GENETIC TESTING MARKET SHARE BY DISEASE TYPE, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL GENETIC TESTING MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 US GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UK GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 ITALY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ROE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF THE WORLD GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL GENETIC TESTING MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL GENETIC TESTING MARKET SHARE BY TYPE, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL GENETIC TESTING MARKET SHARE BY DISEASE TYPE, 2017 VS 2023 (IN %)
FIGURE # 4 GLOBAL GENETIC TESTING MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 5 US GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UK GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 ITALY GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ROE GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF THE WORLD GENETIC TESTING MARKET SIZE, 2017-2023 ($ MILLION)
